Clinical Trial Update: A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II trial evaluating MB-6 in combination with FOLFOX4 for metastatic colorectal cancer and notes that results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• MB-6 (MB-6)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Microbio Co Ltd | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-13